Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current development of podophyllotoxins

R Canetta, P Hilgard, S Florentine

    Cancer Chemotherapy and Pharmacology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.

    Minerva gastroenterologica e dietologica·2011
    Same author

    Selective cytostatic activity of hexadecylphosphocholine against tumor-cells invitro leads to the establishment of an invivo screening system for phospholipid analogs.

    International journal of oncology·2011
    Same author

    Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation.

    Clinical nephrology·2010
    Same author

    [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].

    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2010
    Same author

    Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.

    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2010
    Same author

    Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification.

    Journal of clinical microbiology·2010
    Same journal

    Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights.

    Cancer chemotherapy and pharmacology·2026
    Same journal

    The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

    Cancer chemotherapy and pharmacology·2026
    Same journal

    Composition and structure of stratum corneum intercellular lipids in patients with osimertinib-induced hand-foot syndrome.

    Cancer chemotherapy and pharmacology·2026
    Same journal

    CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.

    Cancer chemotherapy and pharmacology·2026
    Same journal

    ALK rearrangements and resistance mutations in non-small cell lung cancer: molecular mechanisms and therapeutic implications.

    Cancer chemotherapy and pharmacology·2026
    Same journal

    Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications.

    Cancer chemotherapy and pharmacology·2026
    See all related articles

    Podophyllotoxin derivatives, teniposide (Vumon) and etoposide (Vepesid), show unique biological properties and therapeutic efficacy. Research is advancing their use in cancer chemotherapy through new formulations and synergistic combinations.

    Area of Science:

    • Pharmacology
    • Oncology
    • Medicinal Chemistry

    Background:

    • Podophyllotoxin derivatives, teniposide (Vumon) and etoposide (Vepesid), possess unique biological properties and therapeutic efficacy.
    • These agents are of significant interest to both laboratory and clinical researchers in oncology.

    Purpose of the Study:

    • To review current investigations on new pharmaceutical formulations, pharmacokinetics, and metabolism of teniposide and etoposide.
    • To highlight synergistic interactions with other chemotherapeutic agents and define the roles of these drugs in cancer treatment.

    Main Methods:

    • Review of ongoing research in pharmaceutical formulation, pharmacokinetics, and metabolism.
    • Analysis of experimental chemotherapy data, including synergistic effects.
    • Evaluation of clinical trials for single-agent and combination therapies.

    Related Experiment Videos

    Main Results:

    • New insights into drug administration are emerging from pharmacokinetic and metabolism studies.
    • Cytosine arabinoside and cisplatin demonstrate high synergy with podophyllotoxins.
    • Clinical trials are actively defining the roles of teniposide and etoposide in cancer chemotherapy.

    Conclusions:

    • Teniposide and etoposide are valuable agents in cancer chemotherapy.
    • Further research into formulations and combinations will optimize their therapeutic application.
    • Understanding pharmacokinetics and metabolism is crucial for appropriate drug administration.